Achieve Life Sciences

This Phase 3 trial tested whether adding custirsen to the chemotherapy drug docetaxel helps people with advanced non-small cell lung cancer live longer. The study involved 664 patients who had already tried one platinum-based treatment. Researchers compared survival between those…

This study tested a pill called cytisinicline, made from a plant compound, to see if it helps adults stop using nicotine e-cigarettes. 160 daily vapers took either the drug or a placebo for 12 weeks, along with brief counseling. The main goal was to see if more people could quit …

This study tested a pill called cytisinicline to help adults stop smoking. Over 800 daily smokers took the pill or a placebo for 6 or 12 weeks. The goal was to see if the pill helped them stay smoke-free, verified by breath tests. Results showed it was effective for quitting smok…

This phase 3 trial tested cytisinicline, a plant-based pill, in 792 adult smokers who wanted to quit. Participants took the pill or a placebo for 6 or 12 weeks, plus brief behavioral support. The study measured smoking abstinence using carbon monoxide tests. Results showed that c…

This completed Phase 3 study tested the long-term safety of cytisinicline, a plant-based pill, taken three times daily for 52 weeks by 479 adults who previously took part in smoking or vaping cessation trials. The main goal was to track serious side effects. Researchers hope this…